Other formats:
BibTeX
LaTeX
RIS
@article{2213739,
author = {GBD 2019 Cancer Risk Factors Collaborators and Riad, Abanoub and Klugar, Miloslav and Klugarová, Jitka and Hussain, Mohammad Salman},
article_location = {ELSEVIER SCIENCE INC},
article_number = {10352},
doi = {http://dx.doi.org/10.1016/S0140-6736(22)01438-6},
language = {eng},
issn = {0140-6736},
journal = {The Lancet},
title = {The global burden of cancer attributable to risk factors, 2010-19: a systematic analysis for the Global Burden of Disease Study 2019},
url = {https://www.thelancet.com/journals/lancet/article/PIIS0140-6736(22)01438-6/fulltext#%20},
volume = {400},
year = {2022}
}
TY - JOUR
ID - 2213739
AU - GBD 2019 Cancer Risk Factors Collaborators - Riad, Abanoub - Klugar, Miloslav - Klugarová, Jitka - Hussain, Mohammad Salman
PY - 2022
TI - The global burden of cancer attributable to risk factors, 2010-19: a systematic analysis for the Global Burden of Disease Study 2019
JF - The Lancet
VL - 400
IS - 10352
SP - 563-591
EP - 563-591
PB - NEW YORK
SN - 01406736
UR - https://www.thelancet.com/journals/lancet/article/PIIS0140-6736(22)01438-6/fulltext#%20
N2 - Background Understanding the magnitude of cancer burden attributable to potentially modifiable risk factors is crucial for development of effective prevention and mitigation strategies. We analysed results from the Global Burden of Diseases, Injuries, and Risk Factors Study (GBD) 2019 to inform cancer control planning efforts globally. Methods The GBD 2019 comparative risk assessment framework was used to estimate cancer burden attributable to behavioural, environmental and occupational, and metabolic risk factors. A total of 82 risk–outcome pairs were included on the basis of the World Cancer Research Fund criteria. Estimated cancer deaths and disability-adjusted life-years (DALYs) in 2019 and change in these measures between 2010 and 2019 are presented. Findings Globally, in 2019, the risk factors included in this analysis accounted for 4·45 million (95% uncertainty interval 4·01–4·94) deaths and 105 million (95·0–116) DALYs for both sexes combined, representing 44·4% (41·3–48·4) of all cancer deaths and 42·0% (39·1–45·6) of all DALYs. There were 2·88 million (2·60–3·18) risk-attributable cancer deaths in males (50·6% [47·8–54·1] of all male cancer deaths) and 1·58 million (1·36–1·84) risk-attributable cancer deaths in females (36·3% [32·5–41·3] of all female cancer deaths). The leading risk factors at the most detailed level globally for risk-attributable cancer deaths and DALYs in 2019 for both sexes combined were smoking, followed by alcohol use and high BMI. Risk-attributable cancer burden varied by world region and Socio-demographic Index (SDI), with smoking, unsafe sex, and alcohol use being the three leading risk factors for risk-attributable cancer DALYs in low SDI locations in 2019, whereas DALYs in high SDI locations mirrored the top three global risk factor rankings. From 2010 to 2019, global risk-attributable cancer deaths increased by 20·4% (12·6–28·4) and DALYs by 16·8% (8·8–25·0), with the greatest percentage increase in metabolic risks (34·7% [27·9–42·8] and 33·3% [25·8–42·0]). Interpretation The leading risk factors contributing to global cancer burden in 2019 were behavioural, whereas metabolic risk factors saw the largest increases between 2010 and 2019. Reducing exposure to these modifiable risk factors would decrease cancer mortality and DALY rates worldwide, and policies should be tailored appropriately to local cancer risk factor burden.
ER -
GBD 2019 Cancer Risk Factors Collaborators. The global burden of cancer attributable to risk factors, 2010-19: a systematic analysis for the Global Burden of Disease Study 2019. \textit{The Lancet}. ELSEVIER SCIENCE INC: NEW YORK, 2022, vol.~400, No~10352, p.~563-591. ISSN~0140-6736. Available from: https://dx.doi.org/10.1016/S0140-6736(22)01438-6.
|
